Traws Pharma, Inc.
TRAW
$1.88
$0.021.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 87.00% | -671.37% | -778.84% | -597.51% | -557.53% |
| Total Depreciation and Amortization | -64.71% | -47.06% | -25.00% | -12.50% | 21.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -101.08% | 8,883.59% | 10,913.99% | 9,049.50% | 9,455.39% |
| Change in Net Operating Assets | -56.38% | -658.33% | -2,083.72% | -657.18% | -281.07% |
| Cash from Operations | -16.21% | -72.94% | -66.14% | -73.60% | -37.81% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -25,957.14% | -25,957.14% | -25,957.14% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 66.95% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 64.90% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 940.00% | 466.67% | -290.00% | -109.68% | -138.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.37% | 97.46% | 102.88% | -14.19% | 23.57% |